Distinct CD1d docking strategies exhibited by diverse Type II NKT cell receptors
Type I and type II natural killer T (NKT) cells are restricted to the lipid antigen-presenting molecule CD1d. While we have an understanding of the antigen reactivity and function of type I NKT cells, our knowledge of type II NKT cells in health and disease remains unclear. Here we describe a population of type II NKT cells that recognise and respond to the microbial antigen, α-glucuronosyl-diacylglycerol (α-GlcADAG) presented by CD1d, but not the prototypical type I NKT cell agonist, α-galactosylceramide. Surprisingly, the crystal structure of a type II NKT TCR-CD1d-α-GlcADAG complex reveals a CD1d F'-pocket-docking mode that contrasts sharply with the previously determined A'-roof positioning of a sulfatide-reactive type II NKT TCR. Our data also suggest that diverse type II NKT TCRs directed against distinct microbial or mammalian lipid antigens adopt multiple recognition strategies on CD1d, thereby maximising the potential for type II NKT cells to detect different lipid antigens.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2019 |
|---|---|
| Erschienen: |
2019 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:10 |
|---|---|
| Enthalten in: |
Nature communications - 10(2019), 1 vom: 20. Nov., Seite 5242 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Almeida, Catarina F [VerfasserIn] |
|---|
| Links: |
|---|
| Anmerkungen: |
Date Completed 02.03.2020 Date Revised 10.01.2021 published: Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1038/s41467-019-12941-9 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM30351339X |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM30351339X | ||
| 003 | DE-627 | ||
| 005 | 20231225113001.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2019 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1038/s41467-019-12941-9 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1011.xml |
| 035 | |a (DE-627)NLM30351339X | ||
| 035 | |a (NLM)31748533 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Almeida, Catarina F |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Distinct CD1d docking strategies exhibited by diverse Type II NKT cell receptors |
| 264 | 1 | |c 2019 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 02.03.2020 | ||
| 500 | |a Date Revised 10.01.2021 | ||
| 500 | |a published: Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Type I and type II natural killer T (NKT) cells are restricted to the lipid antigen-presenting molecule CD1d. While we have an understanding of the antigen reactivity and function of type I NKT cells, our knowledge of type II NKT cells in health and disease remains unclear. Here we describe a population of type II NKT cells that recognise and respond to the microbial antigen, α-glucuronosyl-diacylglycerol (α-GlcADAG) presented by CD1d, but not the prototypical type I NKT cell agonist, α-galactosylceramide. Surprisingly, the crystal structure of a type II NKT TCR-CD1d-α-GlcADAG complex reveals a CD1d F'-pocket-docking mode that contrasts sharply with the previously determined A'-roof positioning of a sulfatide-reactive type II NKT TCR. Our data also suggest that diverse type II NKT TCRs directed against distinct microbial or mammalian lipid antigens adopt multiple recognition strategies on CD1d, thereby maximising the potential for type II NKT cells to detect different lipid antigens | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Research Support, Non-U.S. Gov't | |
| 650 | 7 | |a Antigens, CD1d |2 NLM | |
| 650 | 7 | |a Galactosylceramides |2 NLM | |
| 650 | 7 | |a Glycolipids |2 NLM | |
| 650 | 7 | |a Receptors, Antigen, T-Cell |2 NLM | |
| 650 | 7 | |a Receptors, Antigen, T-Cell, alpha-beta |2 NLM | |
| 650 | 7 | |a alpha-galactosylceramide |2 NLM | |
| 650 | 7 | |a glucuronosyl diacylglycerol |2 NLM | |
| 700 | 1 | |a Sundararaj, Srinivasan |e verfasserin |4 aut | |
| 700 | 1 | |a Le Nours, Jérôme |e verfasserin |4 aut | |
| 700 | 1 | |a Praveena, T |e verfasserin |4 aut | |
| 700 | 1 | |a Cao, Benjamin |e verfasserin |4 aut | |
| 700 | 1 | |a Burugupalli, Satvika |e verfasserin |4 aut | |
| 700 | 1 | |a Smith, Dylan G M |e verfasserin |4 aut | |
| 700 | 1 | |a Patel, Onisha |e verfasserin |4 aut | |
| 700 | 1 | |a Brigl, Manfred |e verfasserin |4 aut | |
| 700 | 1 | |a Pellicci, Daniel G |e verfasserin |4 aut | |
| 700 | 1 | |a Williams, Spencer J |e verfasserin |4 aut | |
| 700 | 1 | |a Uldrich, Adam P |e verfasserin |4 aut | |
| 700 | 1 | |a Godfrey, Dale I |e verfasserin |4 aut | |
| 700 | 1 | |a Rossjohn, Jamie |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Nature communications |d 2010 |g 10(2019), 1 vom: 20. Nov., Seite 5242 |w (DE-627)NLM199274525 |x 2041-1723 |7 nnns |
| 773 | 1 | 8 | |g volume:10 |g year:2019 |g number:1 |g day:20 |g month:11 |g pages:5242 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1038/s41467-019-12941-9 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 10 |j 2019 |e 1 |b 20 |c 11 |h 5242 | ||